A phase 3 trial does not support #NicotinamideRiboside for early #ParkinsonDisease treatment. The findings are clinically relevant given the widespread use of this supplement and ongoing related trials.
📌 Learn more: ja.ma/4Afh4Xp
#Nicotinamide #ParkinsonDisease #VitaminB3 #supplements
A phase 3 trial does not support #NicotinamideRiboside for early #ParkinsonDisease treatment. The findings are clinically relevant given the widespread use of this supplement and ongoing related trials. 📌 Learn more: ja.ma/4Afh4Xp #Nicotinamide #ParkinsonDisease #VitaminB3 #supplements
0 vue
Publié le 06/11/2026 14:00
A phase 3 trial does not support #NicotinamideRiboside for early #ParkinsonDisease treatment. The findings are clinically relevant given the widespread use of this supplement and ongoing related trials.
📌 Learn more: ja.ma/4Afh4Xp
#Nicotinamide #ParkinsonDisease #VitaminB3 #supplements
0 commentaire
?